ARTV vs BKNG · $37.3M cap vs P/E 36, rev $7.35B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Booking Holdings Inc (BKNG) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Booking Holdings Inc (BKNG) is a travel services company listed on US. It is led by Glenn D. Fogel.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported BKNG revenue for 2026-06-30 was $7.35B. Revenue was up 32.9% from 2026-03-31 to 2026-06-30. BKNG currently screens at market cap $186.03B and trailing P/E 35.6.
ARTV currently screens at market cap $37.3M. BKNG currently screens at market cap $186.03B and trailing P/E 35.6.
Not investment advice. Open the ARTV and BKNG stock pages for the full models.
Not investment advice.